RHINO BCG MATRIX TEMPLATE RESEARCH B_81 ready to use for strategic

ready to use for strategic planning and investment decisions

That free cash helps fund Owkin's BASI R&D roadmap-Owkin allocated ~€30M capex/R&D in 2025-with RL-Learner expected to finance a meaningful share of ongoing development

Example: Medtronic’s licensing revenue in 2024 was $1

This model is gaining traction: in 2024

Clinical Development Costs: Expenses for trials and data analysis

RHINO BCG MATRIX TEMPLATE RESEARCH B_81 ready to use for strategicVisual. Strategic. Downloadable. The Rhino BCG Matrix previews how the company's portfolio maps into Stars, Cash Cows, Dogs, and Question Marks highlighting where growth, cash generation, or divestment decisions matter most; this snapshot flags immediate strategic priorities and risk concentrations. Purchase the full BCG Matrix for quadrant level data, clear investment recommendations, and a ready to use Word report plus an Excel summary that lets you